Skip to main content

Table 1 Southern blot analysis of PCR-amplified bcl-xlong and bcl-xshort products from AML cells

From: Ratio of bcl-xshort to bcl-xlong Is Different in Good- and Poor-Prognosis Subsets of Acute Myeloid Leukemia

Patient

bclxl/bclxs

Cytogenetics

Patient

bclxl/bclxs

Cytogenetics

SN

5.0

-7

AE

1.9

t8;21

SS

2.7

+8

FY

1.8

+22,+8,inv16

HS

2.2

-7,inv3

BE

1.6

+8

SR

2.2

-9q,t8;21

MY

1.6

t8;21

HT

2.1

-5-7

EE

1.3

inv16

LE

1.9

-5-7

HE

1.3

inv16

LN

1.9

-5-7

TE

1.2

t8;21

  1. RT-PCR was carried out with total RNA as templates and bcl-x specific oligonucleotides as primers. The PCR products were separated by agarose gel electrophoresis, transfered to nylon membrane in alkaline solution and hybridized with radioactive probes derived from bcl-x cDNA. The filter was exposed to multiple X-ray films. The ratio between the bcl-xlong signal and bcl-xshort signals was calculated from the image intensity on the films.